OCCYO logo

OCCYO

Intelligent Ocular Imaging

13 employees · est. 2019 · Innsbruck, Austria

VS
Speclipse, Inc. logo

Speclipse, Inc.

World leader in the development of skin cancer diagnostic solutions based on LIPS and AI technology.

12 employees · est. 2015 · Sunnyvale, United States

Speclipse, Inc. is the older company (2019 vs 2015).

Side-by-Side Comparison

OCCYO Speclipse, Inc.
Founded
2019 2015 older
Headquarters
Innsbruck, Austria Sunnyvale, United States
Employees
13 12
Industry
Health Care, Manufacturing, Medical Devices Biotechnology, Health Care
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
Not tracked yet Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Ocular Imaging, Telemedicine, Remote Diagnosis, High Resolution Imaging, Diagnostic Technology, Decentralized Healthcare, Eye Care Technology Not tracked yet
Website
occyo.com speclipse.com
OCCYO logo

About OCCYO

OCCYO is a health care startup based in Austria, founded in 2019, with a mission to revolutionize patient eye care through "Intelligent Ocular Imaging." Their focus is on making ocular surface imaging more accurate and accessible globally. The company harnesses technology and telemedicine to enable...

Speclipse, Inc. logo

About Speclipse, Inc.

Speclipse, Inc. is a pioneering medical device developer that specializes in skin cancer diagnostic solutions. Using laser-induced plasma spectroscopy (LIPS) and artificial intelligence (AI) technology, the company has created Spectra-Scope®, the world's first real-time, non-invasive, in-vivo diagno...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at OCCYO and Speclipse, Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at OCCYO and Speclipse, Inc. — by email.

Frequently Asked Questions

OCCYO — Intelligent Ocular Imaging. Speclipse, Inc. — World leader in the development of skin cancer diagnostic solutions based on LIPS and AI technology.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
OCCYO and Speclipse, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare OCCYO with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy